These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


378 related items for PubMed ID: 25857658

  • 21. Transcallosal bands: a sign of neuronal tract degeneration in early MS?
    Simon JH, Jacobs L, Kinkel RP.
    Neurology; 2001 Nov 27; 57(10):1888-90. PubMed ID: 11723282
    [Abstract] [Full Text] [Related]

  • 22. Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging.
    Simon JH, Schiffer RB, Rudick RA, Herndon RM.
    AJNR Am J Neuroradiol; 1987 Nov 27; 8(4):599-604. PubMed ID: 3113196
    [Abstract] [Full Text] [Related]

  • 23. Neuroimaging of Multiple Sclerosis Mimics.
    Haralur Y, Mechtler LL.
    Neurol Clin; 2020 Feb 27; 38(1):149-170. PubMed ID: 31761056
    [Abstract] [Full Text] [Related]

  • 24. [Case of suspected multiple sclerosis with transcallosal lesions involving the upper surface of the corpus callosum].
    Shirafuji T, Oya Y, Nakamura H, Ogata K, Ogawa M, Kawai M.
    Rinsho Shinkeigaku; 2008 May 27; 48(5):321-7. PubMed ID: 18540378
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Multiple sclerosis: atrophy of the corpus callosum and psychosyndrome].
    Weihe W, Loew M, Schulze-Siedschlag J, Horstmann A, Welter FL, Mariss G.
    Nervenarzt; 1989 Jul 27; 60(7):414-9. PubMed ID: 2761662
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
    Oh J, Pelletier D, Nelson SJ.
    Arch Neurol; 2004 Jul 27; 61(7):1081-6. PubMed ID: 15262739
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Common Clinical and Imaging Conditions Misdiagnosed as Multiple Sclerosis: A Current Approach to the Differential Diagnosis of Multiple Sclerosis.
    Siva A.
    Neurol Clin; 2018 Feb 27; 36(1):69-117. PubMed ID: 29157405
    [Abstract] [Full Text] [Related]

  • 38. Tumefactive demyelinating lesion. Trying to find unity in diversity. Comparison of two cases.
    Adamek D, Radwanska E, Rog T, Grzywna E, Herman-Sucharska I.
    Clin Neurol Neurosurg; 2014 Jan 27; 116():90-2. PubMed ID: 24269051
    [No Abstract] [Full Text] [Related]

  • 39. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
    Kiriyama T, Kataoka H, Taoka T, Tonomura Y, Terashima M, Morikawa M, Tanizawa E, Kawahara M, Furiya Y, Sugie K, Kichikawa K, Ueno S.
    J Neuroimaging; 2011 Apr 27; 21(2):e69-77. PubMed ID: 20572907
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.